A research report on the global digital diabetes management market predicts that the market will grow at a CAGR of 13.5 % between 2024 and 2033 , and is further projected to generate a market size of USD 61.1 billion by the end of 2033. In 2024, the market size was USD 19.2 billion .
Currently, diabetes can be effectively tracked and managed with the help of technology and digital tools such as apps, digital devices, health metrics, and various tracking platforms, helping patients by tracking blood glucose levels and providing other health benefits, among others. Recently, a surge in diabetes patients globally is boosting the digital diabetes management market during the forecast period. According to a 2021 report by the International Diabetes Federation, 10.5% of the adult population (aged 20-79 years) suffers from diabetes, and half of the population is completely unaware that they have it. F. Hoffmann-La Roche Ltd., Bayer AG, and Lifescan, Inc. are some of the key players in the global digital diabetes management market.
Comments
0 comment